Interventional Oncology Market

The  interventional oncolgy market is projected to reach USD  4.24 billion by 2029 from USD 2.75 billion in 2024, at a CAGR of 9.0% from 2024  to 2029. The interventional oncology market has been growing based on the fact that cancer patients are increasing and there is increased demand for a minimally invasive treatment. Techniques include radiofrequency ablation, microwave ablation, and transarterial chemoembolization, which result in targeted therapeutic options with the least recovery periods and complications of traditional surgeries. Moreover, other factors driving growth in the oncology market have been supportive government initiatives, good healthcare infrastructure, and increasing investment in oncology-focused research and technologies.

The prominent players in the poultry pharmaceuticals market are Siemens Healthineers AG (Varian) (US), Medtronic (Ireland), Boston Scientific Corporation (US), Terumo Corporation (Japan), Merit Medical Systems (US).

To know about the assumptions considered for the study download the pdf brochure

Siemens Healthineers AG (Varian) (US)

This subsidiary Varian Medical Systems of Siemens Healthineers AG leads market demand by innovative solutions in the niche of cancer treatment and remains an important player in the interventional oncology market. VARIAN focuses on advanced radiation therapy, radiosurgery, and interventional oncology systems to enhance the precision and outcome of tumor ablation and embolization procedures. Varian company has a comprehensive portfolio of product lines that entail advanced image guided treatment systems as well as solution software for therapy planning, thereby integrating oncology information systems whose workflows combine well with both therapeutic and diagnostic phases. It borrows imaging-related expertise from the Siemens Healthineers firm. Such synergy will put the company at the helm of offering integrated, state-of-the-art solutions in interventional oncology towards personal, precise, and efficient cancer care.

Medtronic (Ireland)

Medtronic is one of the biggest leaders in healthcare technology, accounting for many places in interventional oncology. The company develops solutions aimed at improving the outcomes of minimally invasive cancer treatments and focuses on products for tumor ablation and embolization. Medtronic's portfolio includes microwave and cryoablation systems that allow for accurate tumor targeting and destruction for liver, kidney, bone, and lung cancers. Their interventional oncology solutions support advanced imaging and navigation tools for improved procedural accuracy and patient safety. Medtronic is devoted to research and development, strategic collaborations, and comprehensive training programs for healthcare professionals, positioning the company as one of the biggest players in promoting innovation and access to cancer care worldwide.

Boston Scientific Corporation (US)

Boston Scientific Corporation is the leading medical technology company with innovative solutions in a number of therapeutic areas including interventional oncology. It has a rich portfolio of minimally invasive devices to diagnose and treat various types of cancers. These include the TheraSphere Y-90 Glass Microspheres for the radioembolization therapy in liver cancer, along with specialty catheters and guidewires designed for precise targeting of the tumor.Boston Scientific continues to advance patient care by combining the latest in imaging guidance with precision treatment technologies. The company is placed at the front of the interventional oncology market based on its commitment to innovation, clinical research, and strategic partnerships as the demand for targeted, minimally invasive cancer therapies continues to rise.

Related Reports:

Interventional Oncology Market by Devices & Consumables (RF, microwave, cryoablation. embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]